Refine by
Diabetes Patient Technology
7 companies found
Technologybased inBasel, SWITZERLAND
Aurealis Therapeutics, a Swiss-Finnish private biopharmaceutical company, is now entering the clinical trial phase with its patented three-in-one combination product AUP-16 for chronic non-healing wounds and other regenerative diseases. The ...
Our new approach to chronic wound healing moves far beyond symptom ...
Technologybased inNes-Ziona, ISRAEL
Kadimastem is a bio-pharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. ...
Technologybased inFairfield, CONNECTICUT (USA)
GE is Imagination at work. From jet engines to power generation, financial services to water processing, and medical imaging to media content, GE people worldwide are dedicated to turning imaginative ideas into leading products and services that ...
For over 100 years, GE has used its global presence and new technologies to create and better the consumer products we depend on. From telephones to computer accessories to audio/video solutions and beyond, GE is making life easier and more ...
Technologybased inAllentown, PENNSYLVANIA (USA)
RemetricHealth is an industry-leading, fully integrated remote patient monitoring and telehealth technology and service company that helps physician groups, hospitals, home health agencies and payers improve patient outcomes for high-risk patients ...
Our remote patient monitoring/video telehealth programs help healthcare providers monitor real-time biometrics, symptoms, and patient compliance and track trends over time to improve outcomes and reduce ...
Technologybased inUrdorf, SWITZERLAND
Securecell AG specializes in pioneering advanced solutions within the biotech and MedTech industries. Their technological innovations focus on automated bioprocessing, high-throughput sampling, and the deployment of digital technologies to enhance ...
Our immense knowledge of connecting expansive bioprocessing systems, microfluidics and documenting processes down to the molecular level led us to solutions that could greatly impact the Artificial Pancreas Device System (APDS) market for a ...
Technologybased inHillsboro, OREGON (USA)
Diabetomics, Inc. is a global, commercial stage medical diagnostics company pioneering innovative, non-invasive point-of-care tests that are especially useful in alleviating the substantial economic and public health burden of maternal health and ...
The first and only point-of-care tests for early detection of type-1 diabetes and LADA (Latent Autoimmune Diabetes in ...
Technologybased inToronto, ONTARIO (CANADA)
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes. This pre-clinical technology is directed at regulating a hormone in the pancreas called somatostatin which in Type ...
Zucara Therapeutics is developing ZT-01, a first-in-class, once-daily therapeutic to prevent insulin-induced hypoglycemia in patients using insulin therapy. ZT-01 is designed to inhibit somatostatin, a pancreatic hormone that ...